December 04, 2014
2 min read
Save

Anterior chamber, scleral-fixated IOLs yield similar long-term outcomes

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Primary anterior chamber IOL implantation and secondary scleral-fixated IOL implantation after complicated cataract surgery in eyes with inadequate capsular support yielded comparable long-term visual outcomes and complication rates, according to a study.

The retrospective study included 89 eyes implanted with a primary anterior chamber IOL (ACIOL) and 74 eyes implanted with a secondary scleral-fixated IOL. Mean follow-up was 64.1 months.

Eyes in the ACIOL group received a single-piece, four-point fixation, open-loop polymethyl methacrylate (PMMA) flexible lens, either the Pharmacia 351C (Pharmacia International) or the S112UV (Bausch + Lomb). Eyes in the secondary scleral-fixated IOL group received a single-piece PMMA IOL with eyelets (MCZ70BD, Alcon).

Mean postoperative BCVA was 0.32 in the primary ACIOL group and 0.34 in the secondary scleral-fixated IOL group at 1 year. The between-group difference was statistically insignificant.

Mean latest BCVA was 0.68 in the primary ACIOL group and 0.61 in the secondary scleral-fixated IOL group. The difference was insignificant.

Both groups had a similar proportion of eyes with BCVA of 20/40 or better at 1 year and final follow-up.

Early postoperative complications within 1 month occurred in 62 of 89 eyes (69.7%) in the primary ACIOL group and in 29 of 74 eyes in the secondary IOL group (39.7%). The between-group difference was statistically significant (P < .001). However, both groups had the same rate of late postoperative complications after 1 month.

“Primary ACIOL implantation allows immediate aphakic correction without prolonging the complicated operation extensively. … On the other hand, secondary scleral-fixated IOL implantation allows better surgical planning in a more controlled situation,” the study authors wrote.

Disclosure: The study authors report no relevant financial disclosures.